Since purchasing Solexa with its Genome Reader instrument in 2007, Illumina’s continued innovation significantly reduced the cost of sequencing, thereby enabling the rapid expansion of ...
In June 2007, Stanford's David Johnson teamed up with Barbara Wold of Pasadena's California Institute of Technology, using Illumina's Solexa platform to develop a high-throughput method for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback